{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:20:45Z","timestamp":1742383245802,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s13730-021-00603-z","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T12:17:42Z","timestamp":1619612262000},"page":"537-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition disease"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-9907","authenticated-orcid":false,"given":"Shinichi","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigusa","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinobu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"issue":"13","key":"603_CR1","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E, et al. International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol. 2016;34(13):1544\u201357.","journal-title":"J Clin Oncol"},{"issue":"9","key":"603_CR2","doi-asserted-by":"publisher","first-page":"E348","DOI":"10.1002\/ajh.24447","volume":"91","author":"JC Yui","year":"2016","unstructured":"Yui JC, Keer JV, Weiss BM, Waxman AJ, Palmer MB, D\u2019Agati VD, et al. Proteasome inhibitor associated thrombotic microangiopathy. Am J Hematol. 2016;91(9):E348\u201352.","journal-title":"Am J Hematol"},{"key":"603_CR3","doi-asserted-by":"publisher","unstructured":"Keer JV, Delforge M, Dierickx D, Peerlinck K, Lerut E, Spranogers B. Renal thrombotic microangiopathy associated with the use of bortezomib in a patient with multiple myeloma [published online ahead of print May 16, 2016]. Case Report Hematol. https:\/\/doi.org\/10.1155\/2016\/6020691.","DOI":"10.1155\/2016\/6020691"},{"key":"603_CR4","doi-asserted-by":"publisher","unstructured":"Fonseca NM, Cardoso F, Monteiro M, G\u00f3is M, Sousa H, Fidalgo T, et al. A case of bortezomib-associated thrombotic microangiopathy in multiple myeloma [published online ahead of print Dec 26, 2019]. J Onco-Nephrol. https:\/\/doi.org\/10.1177\/2399369319894343.","DOI":"10.1177\/2399369319894343"},{"issue":"6","key":"603_CR5","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/his.13716","volume":"73","author":"F Pfister","year":"2018","unstructured":"Pfister F, Amann K, Daniel C, Klewer M, B\u00fcttner A, B\u00fcttner-Herold M. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy. Histopathology. 2018;73(6):990\u20131001.","journal-title":"Histopathology"},{"issue":"5","key":"603_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41379-018-0186-4","volume":"32","author":"F Person","year":"2019","unstructured":"Person F, Rinschen MM, Brix SR, Wulf S, Noriega MLM, Fehrle W, et al. Bevacizumab-associated glomerular microangiopathy. Mod Pathol. 2019;32(5):684\u2013700.","journal-title":"Mod Pathol"},{"issue":"5","key":"603_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/ckj\/sfv059","volume":"8","author":"A Lodhi","year":"2015","unstructured":"Lodhi A, Kumar A, Saqlain MU, Suneja M. Thrombotic microangiopathy associated with proteasome inhibitor. Clin Kidney J. 2015;8(5):632\u20136.","journal-title":"Clin Kidney J"},{"issue":"6","key":"603_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","volume":"59","author":"SH Nasr","year":"2012","unstructured":"Nasr SH, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, et al. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsy. Am J Kidney Dis. 2012;59(6):786\u201394.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"603_CR9","doi-asserted-by":"publisher","first-page":"E250","DOI":"10.1002\/ajh.25569","volume":"94","author":"JC Yui","year":"2019","unstructured":"Yui JC, Garceau D, Jhaveri KD, Wanchoo R, Bijol V, Glezerman I, et al. Monoclonal gammopathy-associated thrombotic microangiopathy. Am J Hematol. 2019;94(10):E250-253.","journal-title":"Am J Hematol"},{"issue":"10","key":"603_CR10","first-page":"1477","volume":"9","author":"GJ Navis","year":"1994","unstructured":"Navis GJ, Dullaart RPF, Vellenga E, Elema JD, de Jong PE. Renal disease in POEMS syndrome: report on a case and review of the literature. Nephrol Dial Transpl. 1994;9(10):1477\u201381.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"603_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1620\/tjem.231.229","volume":"231","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Nishimura M, Terano T, McNamara KM, Sasano H, Kurosu A, et al. A patient with POEMS syndrome: the pathology of glomerular microangiopathy. Tohoku J Exp Med. 2013;231(3):229\u201334.","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"603_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1053\/j.ajkd.2006.01.004","volume":"47","author":"S Sanada","year":"2006","unstructured":"Sanada S, Ookawara S, Karube H, Shindo T, Goto T, Nakamichi T, et al. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation. Am J Kidney Dis. 2006;47(4):672\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"9002","key":"603_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","volume":"347","author":"O Watanabe","year":"1996","unstructured":"Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet. 1996;347(9002):702.","journal-title":"Lancet"},{"issue":"2","key":"603_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/physrev.00055.2006","volume":"88","author":"B Haraldsson","year":"2008","unstructured":"Haraldsson B, Nystr\u00f6m J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008;88(2):451\u201387.","journal-title":"Physiol Rev"},{"issue":"12","key":"603_CR15","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2215\/CJN.11161111","volume":"7","author":"N Lenug","year":"2012","unstructured":"Lenug N, Gertz M, Kyle A, Fervenza FC, Irazabal MV, Eirin A, et al. Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin J Am Soc Nephrol. 2012;7(12):1964\u20138.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00603-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00603-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00603-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T09:36:05Z","timestamp":1633599365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00603-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00603-z","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}